Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NT Trading, also branded as NT Dental, was a Germany-based dental medical device company focused on the development and manufacture of prosthetic components and digital workflow products for implant dentistry. Its portfolio included abutments, scan bodies, implant analogs, digital implant modeling tools, and CAD/CAM-enabled customized prosthetic solutions. The company positioned itself as a premium manufacturer serving dental laboratories and clinicians across multiple implant systems, with quality certifications aligned to medical device regulations. NT Trading also operated a U.S. sales and logistics subsidiary, NT-US, to support North American commercialization. Public sources indicate the company entered insolvency proceedings in early 2024 and was later listed as in liquidation, although company materials and databases also show it had previously been acquired by Adiuva Capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NT Trading.